These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 33248386
1. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma. Kondo Y, Hirabayashi K, Carreras J, Tsukinoki K, Ota Y, Okami K, Nakamura N. Ann Diagn Pathol; 2021 Feb; 50():151673. PubMed ID: 33248386 [Abstract] [Full Text] [Related]
2. Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness. Moriwaki K, Ayani Y, Kuwabara H, Terada T, Higashino M, Kawata R. Oral Oncol; 2024 Apr; 151():106751. PubMed ID: 38479153 [Abstract] [Full Text] [Related]
3. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma. Soares CD, de Lima Morais TM, Carlos R, Martins MD, de Almeida OP, Mariano FV, Altemani A. Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353 [Abstract] [Full Text] [Related]
6. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma. Ryu HJ, Koh YW, Yoon SO. Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009 [Abstract] [Full Text] [Related]
8. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast. Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T. Histopathology; 2017 Jan; 70(2):164-173. PubMed ID: 27079821 [Abstract] [Full Text] [Related]
9. Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis. Kusafuka K, Kawasaki T, Onitsuka T, Hamaguchi N, Morita K, Mukaigawa T, Nishiya Y, Kamijo T, Iida Y, Nakajima T, Sugino T. Head Neck Pathol; 2020 Mar; 14(1):230-238. PubMed ID: 30484070 [Abstract] [Full Text] [Related]
13. Salivary duct carcinoma: A report of 70 FNA cases and review of the literature. Wakely PE. Cancer Cytopathol; 2022 Aug; 130(8):595-608. PubMed ID: 35255198 [Abstract] [Full Text] [Related]
15. BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma. Jia S, Wang W, Hu Z, Shan C, Wang L, Wu B, Yang Z, Yang X, Lei D. Oral Oncol; 2015 Jan; 51(1):64-70. PubMed ID: 25456007 [Abstract] [Full Text] [Related]
16. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center. Mayer M, Wolber P, Prinz J, Jansen L, Esser J, Shabli S, Quaas A, Klußmann JP, Sharma SJ, Nachtsheim L, Arolt C. Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3779-3789. PubMed ID: 38587651 [Abstract] [Full Text] [Related]
17. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations. Wang K, Russell JS, McDermott JD, Elvin JA, Khaira D, Johnson A, Jennings TA, Ali SM, Murray M, Marshall C, Oldham DS, Washburn D, Wong SJ, Chmielecki J, Yelensky R, Lipson D, Miller VA, Stephens PJ, Serracino HS, Ross JS, Bowles DW. Clin Cancer Res; 2016 Dec 15; 22(24):6061-6068. PubMed ID: 27334835 [Abstract] [Full Text] [Related]
19. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature. Nagao T, Gaffey TA, Serizawa H, Iwaya K, Watanabe A, Yoshida T, Yamazaki K, Sageshima M, Lewis JE. Am J Clin Pathol; 2004 Aug 15; 122(2):222-31. PubMed ID: 15323139 [Abstract] [Full Text] [Related]